Emergent BioSolutions to Release Second Quarter 2020 Financial Results and Conduct Conference Call on July 30, 2020
July 16 2020 - 6:30AM
Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call
on Thursday, July 30, 2020 at 5:00 pm (Eastern Time) to discuss the
financial results for the second quarter of 2020, recent business
developments, revenue guidance for the third quarter of 2020, and
financial outlook for full year 2020.
This conference call can be accessed live by telephone or by
webcast:
Live Teleconference
Information:Dial in number: (855)
766-6521International dial in number: (262)
912-6157Conference ID: 7380905Live Webcast
Information:Visit
https://edge.media-server.com/mmc/p/bkkqx6kk for the live webcast
feed. |
A replay of the call can be accessed on Emergent’s website
emergentbiosolutions.com under “Investors.”
About Emergent BioSolutionsEmergent
BioSolutions is a global life sciences company whose mission is to
protect and enhance life. Through our specialty products and
contract development and manufacturing services, we are dedicated
to providing solutions that address public health threats. Through
social responsibility, we aim to build healthier and safer
communities. We aspire to deliver peace of mind to our patients and
customers so they can focus on what’s most important in their
lives. In working together, we envision protecting or enhancing 1
billion lives by 2030. For more information visit
www.emergentbiosolutions.com. Find us on LinkedIn and follow us on
Twitter @emergentbiosolu and Instagram @life_at_emergent.
Investor Contact:Robert G.
BurrowsVice President, Investor
Relations240-631-3280BurrowsR@ebsi.com
Media Contact:Miko B. NeriSenior
Director, Corporate Communications240-631-3392NeriM@ebsi.com
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Sep 2023 to Sep 2024